Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 3/20 | 0.65 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.50 |
| ▸ | NPY1R | P25929 | 1/20 | 0.49 |
| ▸ | NPY2R | P49146 | 1/20 | 0.49 |
| ▸ | NPY4R | P50391 | 1/20 | 0.49 |
| ▸ | IL1RN | P18510 | 1/20 | 0.47 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
| ▸ | MME | P08473 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29649767 | 0.93 | NAALAD2 (0.68) | NAALAD2ENPEPFOLH1NPY1RNPY2R | |
| SCHEMBL29349540 | 0.93 | NAALAD2 (0.68) | NAALAD2ENPEPFOLH1NPY1RNPY2R | |
| SCHEMBL31575746 | 0.92 | NAALAD2 (0.54) | NAALAD2ENPEPNPY1RNPY2RNPY4R | |
| SCHEMBL31083820 | 0.92 | NAALAD2 (0.54) | NAALAD2ENPEPNPY1RNPY2RNPY4R | |
| SCHEMBL29393258 | 0.92 | NAALAD2 (0.67) | NAALAD2ENPEPFOLH1NPY1RNPY2R | |
| SCHEMBL29418370 | 0.92 | NAALAD2 (0.67) | NAALAD2ENPEPFOLH1NPY1RNPY2R | |
| SCHEMBL38650819 | 0.92 | NAALAD2 (0.67) | NAALAD2ENPEPFOLH1NPY1RNPY2R | |
| SCHEMBL30124150 | 0.91 | NPY4R (0.58) | NAALAD2FOLH1NPY1RNPY2RNPY4R | |
| SCHEMBL30094471 | 0.91 | NAALAD2 (0.65) | NAALAD2ENPEPFOLH1NPY1RNPY2R | |
| SCHEMBL29558226 | 0.89 | NAALAD2 (0.64) | NAALAD2MMEOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3368561-B1 | PREVENTION OF N-TERMINAL TRUNCATION IN IGG LIGHT CHAINS | MEDIMMUNE LTD (GB) | 2025-09-17 | — | — | EP | disclosed |